🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the companies concealed potential risks that the pain reliever posed to children's brain development.

The lawsuit follows a month after Former President Trump publicized an unverified association between taking acetaminophen - alternatively called paracetamol - throughout gestation and autism in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the drug, the sole analgesic recommended for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he claimed they "betrayed America by making money from pain and promoting medication regardless of the dangers."

The manufacturer says there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening countless individuals to boost earnings," the attorney general, from the Republican party, said.

The company commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its official site, the company also stated it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a proven link between consuming paracetamol and autism."

Groups speaking for doctors and medical practitioners concur.

ACOG has declared paracetamol - the primary component in Tylenol - is one of the few options for expectant mothers to manage pain and fever, which can pose major wellness concerns if ignored.

"In over twenty years of studies on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the usage of acetaminophen in any trimester of pregnancy causes brain development issues in offspring," the association said.

The lawsuit mentions recent announcements from the Trump administration in asserting the medication is potentially dangerous.

Last month, Trump caused concern from medical authorities when he advised pregnant women to "resist strongly" not to take acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that doctors should think about restricting the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had pledged in spring to undertake "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a limited time.

But authorities warned that finding a sole reason of autism - thought by researchers to be the consequence of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a form of permanent neurological difference and impairment that influences how individuals perceive and engage with the environment, and is diagnosed using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is seeking federal office - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism.

This legal action seeks to make the firms "remove any marketing or advertising" that states Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the concerns of a group of parents of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in 2022.

A federal judge threw out the legal action, declaring investigations from the parents' expert witnesses was lacking definitive proof.